Pages that link to "Q28305595"
Jump to navigation
Jump to search
The following pages link to Human distribution and release of a putative new gut hormone, peptide YY (Q28305595):
Displaying 50 items.
- Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat (Q21093205) (← links)
- The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin (Q21261893) (← links)
- The gut hormones in appetite regulation (Q21296779) (← links)
- Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway (Q24642429) (← links)
- Neuropeptide Y Y2 receptor in health and disease (Q24648453) (← links)
- Gastrointestinal hormones regulating appetite (Q24669951) (← links)
- Is GLP-1 a hormone: Whether and When? (Q26749196) (← links)
- Altered gut and adipose tissue hormones in overweight and obese individuals: cause or consequence? (Q26779389) (← links)
- The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD) (Q26782555) (← links)
- Therapy for obesity based on gastrointestinal hormones (Q27006777) (← links)
- Distribution of pancreatic polypeptide and peptide YY (Q28217249) (← links)
- Feedback regulation of pancreatic secretion by peptide YY (Q28217259) (← links)
- Peptide YY as a growth factor for intestinal epithelium (Q28217271) (← links)
- Peptide YY and cancer: current findings and potential clinical applications (Q28217274) (← links)
- Characterization of brainstem peptide YY (PYY) neurons (Q28257925) (← links)
- Melanocortin neurons: Multiple routes to regulation of metabolism (Q30234481) (← links)
- Peptide YY, appetite and food intake. (Q30350893) (← links)
- Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity (Q30399390) (← links)
- Regulation of appetite to treat obesity (Q30403705) (← links)
- New advances in models and strategies for developing anti-obesity drugs (Q30429816) (← links)
- Responses of python gastrointestinal regulatory peptides to feeding (Q31030105) (← links)
- The TRPA1 agonist, methyl syringate suppresses food intake and gastric emptying (Q31131497) (← links)
- Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release (Q33423614) (← links)
- Role of surgery in management of type 2 diabetes mellitus (Q33440742) (← links)
- Peptide YY in diabetics treated chronically with an intestinal glucosidase inhibitor (Q33471164) (← links)
- The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism (Q33587361) (← links)
- Ghrelin and peptide YY in postpartum lactating and nonlactating women (Q33592340) (← links)
- Obesity treatment: novel peripheral targets (Q33607971) (← links)
- Impacts of plant-based foods in ancestral hominin diets on the metabolism and function of gut microbiota in vitro (Q33647942) (← links)
- Combinations of drugs in the Treatment of Obesity (Q33664063) (← links)
- Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels (Q33752066) (← links)
- Obesity pharmacotherapy: what is next? (Q33827988) (← links)
- Increased plasma levels of glucose-dependent insulinotropic polypeptide are associated with decreased postprandial energy expenditure after modern Japanese meals (Q33841107) (← links)
- Peptide YY: a gut hormone associated with anorexia during infectious diarrhea in children (Q33874381) (← links)
- PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. (Q33930222) (← links)
- Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses (Q33931373) (← links)
- The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes (Q33941355) (← links)
- The ileal brake: a fifteen-year progress report (Q34027852) (← links)
- Peptidergic regulation of gastrointestinal motility in rodents (Q34078112) (← links)
- Postprandial plasma PYY concentrations are associated with increased regional gray matter volume and rCBF declines in caudate nuclei--a combined MRI and H2(15)O PET study (Q34125438) (← links)
- Obese adolescents show impaired meal responses of the appetite-regulating hormones ghrelin and PYY (Q34133713) (← links)
- Gut hormone PYY(3-36) physiologically inhibits food intake (Q34143493) (← links)
- Adaptation of the exocrine pancreas to dietary fats (Q34151431) (← links)
- Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects (Q34159708) (← links)
- Differential acute postprandial effects of processed meat and isocaloric vegan meals on the gastrointestinal hormone response in subjects suffering from type 2 diabetes and healthy controls: a randomized crossover study (Q34184127) (← links)
- Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein (Q34241085) (← links)
- Variations in peptide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men. (Q34312055) (← links)
- Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats (Q34356012) (← links)
- Effects of bolus doses of fat on small intestinal structure and on release of gastrin, cholecystokinin, peptide tyrosine-tyrosine, and enteroglucagon (Q34375416) (← links)
- Suggestion of new possibilities in approaching individual variability in appetite through constitutional typology: a pilot study (Q34378436) (← links)